Delaware LP · Reg D Rule 506(c) · $25M target raise · 9% target preferred return · 30% GP share · 5-year term.
Private real estate investments carry substantial risk. Fund I is a blind-pool vehicle. The Fund will invest in multiple properties subject to successful acquisition, market conditions, and franchise approval. No specific properties are guaranteed to be acquired. Actual returns depend on property selection, operational execution, market timing, refinance conditions, leverage, and exit timing. The 9% preferred return is a target allocation priority, not a guaranteed return. There is no guarantee that the Fund will achieve the preferred return, residual returns, or any distributions. Investors may lose all or a substantial portion of their capital invested.
Fund I is designed to acquire Hilton, Marriott, and other branded flag limited-service hotels at disciplined entry basis, stabilize operations through Allencrest’s operating platform, and exit via refinance. Target portfolio is 3–5 hotels over 24 months, subject to successful acquisitions and market conditions.
Every hotel is held in a single-purpose entity (SPE) that is bankruptcy-remote from the Fund and from affiliated operating companies. SPE-to-affiliate agreements (management, IP license, brand sub-license) are priced at arm’s length and documented with transfer-pricing support.
Fund I is offered exclusively under Regulation D Rule 506(c). Every subscriber is independently verified as an accredited investor before accepting capital. Self-certification alone is not sufficient.
Final terms are governed in full by the Private Placement Memorandum and Limited Partnership Agreement.
| Vehicle | Delaware Limited Partnership |
| General Partner | Allencrest Group LLC |
| Offering Exemption | Regulation D Rule 506(c) |
| Target Raise | $25,000,000 |
| Minimum Commitment | $50,000 (GP may accept less at its discretion) |
| Management Fee | 1.5% annually |
| Preferred Return | 9% non-compounding, cumulative (target allocation priority, not guaranteed) |
| Carried Interest | 30% GP share of residual profits (70% LP / 30% GP) |
| Investment Period | Annual cycles ending December 31 (beginning December 31, 2026) |
| Fund Term | 5 years + two 1-year extensions at GP discretion |
| Reporting | Quarterly unaudited statements, annual audited financials, annual K-1 |
Final terms are qualified in their entirety by the Private Placement Memorandum and Limited Partnership Agreement. All terms are subject to change at GP discretion prior to closing and are binding only upon execution of final offering documents.
Accredited investors can complete a brief attestation and request the Private Placement Memorandum, Limited Partnership Agreement, and Subscription Package.
Important. This website is general marketing under Regulation D Rule 506(c) and is not an offer or solicitation of securities. Any offer will be made only through the Fund’s Private Placement Memorandum, Limited Partnership Agreement, and Subscription Documents, and only to verified accredited investors. Private investments involve significant risk, including the risk of total loss. Past performance and illustrative returns do not guarantee future results.